Details for 2013735235

Up to date per 01.04.2026

Actions

Title / Product Name

PHARMAZEUTISCHE DARREICHUNGSFORMEN ENTHALTEND 5-CHLOR-N-({(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)-PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2-THIOPHEN-CARBOXAMID

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2013735235

EP Publication Number

2869814

E-Number

786971

Language

PCT Number

EP13063590

Publication Date

13.05.2015 A

06.04.2016 B1

Registration Date

06.04.2016

AT Publication Date

15.04.2016

Application Date

28.06.2013

Registration Number

Priorities

03.07.2012

12174797

IPC

A61K 9/20 20060101AFI20151013BHEP

Maximum Duration of Protection

28.06.2033

Owner

Bayer Pharma AktiengesellschaftMüllerstrasse 178 13353 BerlinDE

Representative

No representatives present

Inventor

BENKE, KlausMalteserweg 16 51465 Bergisch GladbachDE

NEUMANN, HeikeHindenburgstr. 143 42117 WuppertalDE

MÜCK, WolfgangObere Bergerheide 16 42113 WuppertalDE